The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $1,408,553 firm-fixed-price definitive contract to the Regents of the University of Michigan, an educational institution, for "Innovative Strategies for Determining Vaccine Effectiveness Against Influenza and COVID-19 Illness". This contract, which has a completion date of September 30, 2022, does not utilize any set-aside designation.
As a subcontract under this award, Henry Ford Health System, a non-profit integrated healthcare provider, is supporting study activities within the CDC-funded U.S. Flu VE Network's annual estimation of influenza and COVID-19 vaccine effectiveness in reducing the risk of medically-attended, laboratory-confirmed influenza and COVID-19. The Regents of the University of Michigan has a history of providing research and development services to federal agencies like the Department of Veterans Affairs and has received numerous grants from organizations such as the National Institutes of Health, National Science Foundation, and Department of Energy for a variety of research topics.
Generated 4/29/24, 10:03 AM